Cancer Institute A national cancer institute
designated cancer center

Clinical Trials & Research in Head and Neck Cancer

Stanford's Cutting-Edge Research

Study Title
Principal Investigator Stanford Study Status
A Longitudinal Study of Plasma EBV DNA in Nasopharyngeal Carcinoma from Both Endemic and Non-Endemic Patient Populations Quynh-Thu Le Recruiting
Identification and Characterization of Novel Proteins and Genes in Head and Neck Cancer Quynh-Thu Le Recruiting
Identification of Secreted Markers for Tumor Hypoxia in Patients with Head and Neck or Lung Cancers Quynh-Thu Le Recruiting
Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer Harlan Pinto Recruiting
Phase II Sequential and Concurrent Chemoradiation for Advanced Nasopharyngeal Carcinoma (NPC) Dr. A. Dimitrios Colevas Recruiting
Radiation Therapy With or Without Cetuximab in Treating Patients Who Have Undergone Surgery for Locally Advanced Head and Neck Cancer Quynh-Thu Le Recruiting
Phase I Trial of Metabolic Reprogramming Therapy for Treatment of Recurrent Head and Neck Cancers Daniel T Chang Recruiting
A Randomized Phase II Study of Adjuvant Concurrent Radiation and Chemotherapy versus Radiation Alone in Resected High-Risk Malignant Salivary Gland Tumors. Quynh-Thu Le Recruiting
Feasibility of IMRT Modulation to Account for Scattered Radiation from Dental Fillings in H&N Cancer Quynh-Thu Le Recruiting
Weekly Docetaxel, Cisplatin, and Cetuximab (TPC) in Palliative Treatment of Patients with SCCHN Dr. A. Dimitrios Colevas Recruiting
Radiation Therapy With Cisplatin or Cetuximab in Treating Patients With Oropharyngeal Cancer Quynh-Thu Le Recruiting
Phase II MEHD7945A Vs Cetuximab in Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck Dr. A. Dimitrios Colevas Recruiting
Phase I Study of CUDC-101 With Cisplatin and Radiation in Subjects With Head & Neck Cancer Dr. A. Dimitrios Colevas Recruiting

If you would like assistance searching for trials please contact the Stanford Cancer Clinical Trials Office at 650-498-7061 or ccto-office@stanford.edu.

Stanford Medicine Resources:

Footer Links: